Structure of the Molybdenum Site of Rhodobacter sphaeroides Biotin Sulfoxide Reductase

Conditions for heterologous expression of Rhodobacter sphaeroides biotin sulfoxide reductase in Escherichia coli were modified, resulting in a significant improvement in the yield of recombinant enzyme and enabling structural studies of the molybdenum center. Quantitation of the guanine and the moly...

Full description

Saved in:
Bibliographic Details
Published in:Biochemistry (Easton) Vol. 39; no. 14; pp. 4046 - 4052
Main Authors: Temple, Carrie A, George, Graham N, Hilton, James C, George, Martin J, Prince, Roger C, Barber, Michael J, Rajagopalan, K. V
Format: Journal Article
Language:English
Published: United States American Chemical Society 11-04-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conditions for heterologous expression of Rhodobacter sphaeroides biotin sulfoxide reductase in Escherichia coli were modified, resulting in a significant improvement in the yield of recombinant enzyme and enabling structural studies of the molybdenum center. Quantitation of the guanine and the molybdenum as compared to that found in R. sphaeroides DMSO reductase demonstrated the presence of the bis(MGD)molybdenum cofactor. UV−visible absorption spectra were obtained for the oxidized, NADPH-reduced, and dithionite-reduced enzyme. EPR spectra were obtained for the Mo(V) state of the enzyme. X-ray absorption spectroscopy at the molybdenum K-edge has been used to probe the molybdenum coordination of the enzyme. The molybdenum site of the oxidized protein possesses a Mo(VI) mono-oxo site (MoO at 1.70 Å) with additional coordination by approximately four thiolate ligands at 2.41 Å and probably one oxygen or nitrogen at 1.95 Å. The NADPH- and dithionite-reduced Mo(IV) forms of the enzyme are des-oxo molybdenum sites with approximately four thiolates at 2.33 Å and two different Mo−O/N ligands at 2.19 and 1.94 Å.
Bibliography:Research at Duke University was supported by Grant GM00091 from the National Institutes of Health. The Stanford Synchrotron Radiation Laboratory is funded by the Department of Energy, Office of Basic Energy Sciences. The Biotechnology Program is supported by the National Institutes of Health, Biomedical Research Technology Program, Division of Research Resources. Further support is provided by the Department of Energy, Office of Biological and Environmental Research.
istex:97AF03FA56A15D0C546F1425BC36F3177785B5F9
ark:/67375/TPS-GVGFJPJN-M
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0006-2960
1520-4995
DOI:10.1021/bi9921541